Clinical trial
MOTIV Study- Effect of Antidepressive Treatment by Escitalopram in Patients…
NCT00243477 · Hopital Jean Minjoz, Other · Completed
Key facts
| NCT number | NCT00243477 |
|---|---|
| Title | MOTIV Study- Effect of Antidepressive Treatment by Escitalopram in Patients Undergoing Coronary Artery Bypass Grafting |
| Official title | MOTIV Study. Effect of Antidepressive Treatment by Escitalopram Started Preoperatively in Patients Undergoing Coronary Artery Bypass Grafting |
| Lead sponsor | Hopital Jean Minjoz, Other |
| Collaborators | H. Lundbeck A/S Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Coronary Artery Disease |
| Intervention type | Drug |
| Interventions | Escitalopram |
| Enrollment | 368 |
| Start date | Jan 1, 2006 |
| Primary completion | Feb 1, 2011 |
| Completion | Feb 1, 2012 |
| First posted | Oct 24, 2005 |
| Last update posted | Mar 19, 2012 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: